Literature DB >> 8796994

MMP-2: expression, activation and inhibition.

M L Corcoran1, R E Hewitt, D E Kleiner, W G Stetler-Stevenson.   

Abstract

Remodeling of the extracellular matrix (ECM), which occurs during many physiological and pathological processes, is one of the requisite events of cellular invasion. The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases that are responsible for proteolytic degradation of specific ECM components. Regulating the activity of the MMPs at both mRNA and/or protein levels modulates the degradation of the ECM components which in turn alter cellular invasion. Although most MMPs are regulated via similar mechanisms at the mRNA and protein levels, the modulation of gelatinase A is unique. Understanding the mechanisms that regulate gelatinase A is important since expression and activation of this particular MMP is consistently correlated with a majority of malignant phenotypes. In this report, we will contrast the mechanisms that regulate the expression, activation and inhibition of gelatinase A with the mechanisms that modulate the rest the MMP family.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796994     DOI: 10.1159/000468613

Source DB:  PubMed          Journal:  Enzyme Protein        ISSN: 1019-6773


  37 in total

1.  Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells.

Authors:  P S Chen; W R Zhai; X M Zhou; J S Zhang; Y E Zhang; Y Q Ling; Y H Gu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  INS-1 cells inhibit the production of extracellular matrix from pancreatic stellate cells.

Authors:  Fengfei Li; Bijun Chen; Ling Li; Min Zha; S Zhou; Tongzhi Wu; M G Bachem; Zilin Sun
Journal:  J Mol Histol       Date:  2013-11-08       Impact factor: 2.611

3.  Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.

Authors:  Ebony Hoskins; Jaime Rodriguez-Canales; Stephen M Hewitt; Wafic Elmasri; Jasmine Han; Shing Han; Ben Davidson; Elise C Kohn
Journal:  Gynecol Oncol       Date:  2011-06-14       Impact factor: 5.482

4.  Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation.

Authors:  Ana-Maria Bosonea; Xiang Wang; Jeffrey Odenbach; Carlos Fernandez-Patron
Journal:  Drug Discov Today Dis Models       Date:  2011

5.  Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells.

Authors:  A Yoon; R A Hurta
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

6.  Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.

Authors:  Qi Qi; Obiamaka Obianyo; Yuhong Du; Haian Fu; Shiyong Li; Keqiang Ye
Journal:  J Med Chem       Date:  2017-08-18       Impact factor: 7.446

7.  Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2.

Authors:  Sharon Elliot; Paola Catanuto; William Stetler-Stevenson; Scott W Cousins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

8.  Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts.

Authors:  K Migita; T Miyashita; H Ishibashi; Y Maeda; M Nakamura; H Yatsuhashi; H Ida; A Kawakami; T Aoyagi; Y Kawabe; K Eguchi
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium.

Authors:  Françoise Praddaude; Scott W Cousins; Christiane Pêcher; Maria E Marin-Castaño
Journal:  Exp Eye Res       Date:  2009-03-10       Impact factor: 3.467

10.  Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.

Authors:  Maung-Maung Thwin; Eleni Douni; Pachiappan Arjunan; George Kollias; Prem V Kumar; Ponnampalam Gopalakrishnakone
Journal:  Arthritis Res Ther       Date:  2009-09-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.